Pharma Reviews: Indian pharma firms sales to rise after resilience in FY21: Fitch Ratings

Mumbai: Indian pharmaceutical companies' sales will grow robustly in the financial year ending March 2022 (FY22) as sales normalise in categories ...
Read more: Indian pharma firms sales to rise after resilience in FY21: Fitch Ratings